The National Medical Association designates these live in-person activities for a maximum of 1.25 or 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Integrity and Independence, all persons who control the educational content of NMA accredited activities must disclose all financial relationships with any ineligible companies that they have had over the past 24 months. NMA uses the ACCME’s definition of ineligible companies: Those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum financial threshold. NMA determines whether any of those relationships is relevant to this activity. All of the relevant financial relationships identified for persons in a position to control activity content have been mitigated.
See the full biographies for all speakers.
Edward C. Mazique, M.D. Symposium
The Quest for Digital Health Equity: Artificial Intelligence (AI) and the Future of Healthcare
Saturday, August 3, 2024 | 1:00 PM – 3:00 PM
Hilton: Grand Ballroom West, 3rd Floor
2.0 CME Credits
AI and digital innovation have had a significant impact on healthcare. They have improved patient care through personalized treatment plans, remote monitoring, and predictive analytics. However, we want to make sure that as this field expands, all communities and populations will benefit. By the end of the session, participants should have a comprehensive understanding of how AI and digital health technologies can be leveraged to address and transform health disparities into health equity. The audience will also be equipped with practical strategies and ethical considerations for implementation.
The following planners, moderators, and speakers declare no relevant relationships with commercial entities.
Ivor Braden Horn, M.D., M.P.H.
Gary Butts, M.D.
Jeffrey Carter, M.D.
Joe Paul
The following planners, moderators, and speakers declare the following relationships with commercial entities.
Yolanda Lawson, M.D.: Myovant Sciences, Pfizer, Viiv, Pfizer – Advisory Board
Edith Irby Jones, M.D. Plenary
Transforming Healthcare: The Impact of “Big Med”
Sunday, August 4, 2024 | 9:00 AM – 11:00 AM
Hilton: Grand Ballroom West, 3rd Floor
2.0 CME Credits
Large healthcare organizations and corporations are dominating the healthcare industry. These organizations often have significant influence over healthcare policies, practices, and the delivery of care. They can impact patient access to care, quality of care, and healthcare costs. This session will examine the impact of Big Medicine and provide a comprehensive understanding of how Big Medicine is transforming the healthcare landscape, its impact on the workforce, and the implications for health equity. At the conclusion of this session, the audience should be equipped with strategies to navigate these changes, promote workforce well-being, and ensure equitable healthcare access and outcomes.
The following planners, moderators, and speakers declare no relevant relationships with commercial entities.
Darrell Gaskin, Ph.D., M.S.
Keon L. Gilbert, Dr.P.H., M.A., M.P.
Adaeze Enekwechi, Ph.D., M.P.P.
The following planners, moderators, and speakers declare the following relationships with commercial entities.
Yolanda Lawson, M.D.: Myovant Sciences, Pfizer, Viiv, Pfizer – Advisory Board
Special Presidential Plenary
The Justice Imperative Part I: Restorative Justice
Monday, August 5th
8:00 – 9:15 am
Hilton: Murray Hill East
1.25 CME Credits
This panel discussion will delve into the realms of restorative justice emphasizing the importance of holistic solutions that address both ecological and social inequities. During this session, attendees will explore the intersections between justice frameworks and their implications for marginalized communities.
The following planners, moderators, and speakers declare no relevant relationships with commercial entities.
Deleso Alford, J.D.
Georges C. Benjamin, M.D.
Rodney Hood, M.D.
Cong. Robin Kelly
Niva Lubin Johnson, M.D.
William A. McDade, M.D., Ph.D.
The following planners, moderators, and speakers declare the following relationships with commercial entities.
Yolanda Lawson, M.D.: Myovant Sciences, Pfizer, Viiv, Pfizer – Advisory Board
Special Presidential Plenary
The Justice Imperative Part II: Climate & Environmental
Monday, August 5, 2024 | 9:30 AM – 11:00 AM
Hilton: Murray Hill East
1.5 CME Credits
Environmental justice is a human rights and public health issue that ensures everyone has the right to live in healthy, safe environments. Minority and vulnerable communities are commonly the target for environmentally hazardous activities. In these communities the impact of the environment on health can be even more pronounced. These neighborhoods often face greater exposure to environmental hazards such as pollution, industrial waste, and contaminated water sources. Limited access to healthcare and resources for mitigating environmental risks further exacerbates the health disparities in these locales. This session will address these inequities and examine policies and actions that promote social and environmental justice.
The following planners, moderators, and speakers declare no relevant relationships with commercial entities.
John Balbus, M.D., M.P.H.
Jeanne Conry, M.D., Ph.D.
Franciscka Lucien
Peggy Shepard
The following planners, moderators, and speakers declare the following relationships with commercial entities.
Yolanda Lawson, M.D.: Myovant Sciences, Pfizer, Viiv, Pfizer – Advisory Board